Jason Duncan - Apr 22, 2022 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Chief Legal Officer and GC
Signature
/s/ Jason Duncan
Stock symbol
ALBO
Transactions as of
Apr 22, 2022
Transactions value $
-$21,758
Form type
4
Date filed
4/25/2022, 04:38 PM
Previous filing
Jan 25, 2022
Next filing
Jul 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$7.94K -240 -1.44% $33.07 16.4K Apr 22, 2022 Direct F1, F2
transaction ALBO Common Stock Sale -$3.39K -103 -0.63% $32.93 16.3K Apr 22, 2022 Direct F3, F4
transaction ALBO Common Stock Sale -$7.39K -221 -1.35% $33.44 16.1K Apr 25, 2022 Direct F1, F5
transaction ALBO Common Stock Sale -$3.04K -91 -0.57% $33.40 16K Apr 25, 2022 Direct F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
F2 Represents 591 shares of common stock and 15,832 restricted stock units.
F3 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F4 Represents 488 shares of common stock and 15,832 restricted stock units.
F5 Represents 579 shares of common stock and 15,520 restricted stock units.
F6 Represents 488 shares of common stock and 15,520 restricted stock units.